SLC3A2 and breast cancer: As for the hypermethylation of SLC3A2 associated with CTL, results showed no obvious correlation (Fig. 4J), and SLC3A2 gene promoter methylation level referred to no significantly longer survival durations among various molecular subtypes of BC patients (Fig. 4K-O).